Chugai Pharma aims to create high quality innovative drugs

Pharma |  News | 0 Comment | 30 May, 2019

Japanese firm Chugai Pharmaceutical Co., Ltd. has announced the decision to construct a core research laboratory, Chugai Life Science Park Yokohama, at a business site owned in Yokoham...Read more

Samsung Biologics to showcase end-to-end CDMO capabilities at BIO International 2019

Pharma |  News | 0 Comment | 29 May, 2019

For the eighth consecutive year since the company's foundation in 2011, Samsung BioLogics will be showcasing its full end-to-end CDMO capabilities at the BIO International 2019 convention i...Read more

Sihuan Pharma gets clinical trial approval from NMPA

Pharma |  News | 0 Comment | 30 May, 2019

Sihuan Pharmaceutical Holdings Group Ltd., the largest cardio-cerebral vascular drug manufacturer in China's prescription drug market, announced the third generation of EGFR inhibitor XZP-5...Read more

T-FIT® insulation presents leading product T-FIT Clean at P-MEC 2019

Pharma |  News | 0 Comment | 28 May, 2019

T-FIT is a unique, modular technical pipework insulation system purposely designed for highly controlled production environments. Visitors to P-MEC China will have the opportunity to discov...Read more

Vifor Pharma, University of Basel jointly establish the World's First Research Professorship

Pharma |  News | 0 Comment | 28 May, 2019

Nanomedicines are playing an increasingly important role in the development of innovative new medications. These drugs are able to overcome specific cellular barriers in the human body with...Read more

Glenmark receives ANDA approval for Aspirin and generic version of Aggrenox® Capsules

Pharma |  News | 0 Comment | 27 May, 2019

Glenmark Pharmaceuticals has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Aspirin and Extended-Release Dipyridamole Capsules, 25 mg/200 mg,...Read more

Chugai’s Actemra Intravenous Infusion receives additional approval for Adult Still’s Disease

Pharma |  News | 0 Comment | 24 May, 2019

Chugai Pharmaceutical has announced that it has obtained regulatory approval for the humanized anti-human IL-6 receptor monoclonal antibody, “Actemra® Intravenous Infusion 80...Read more

Phebra continues international business expansion

Pharma |  News | 0 Comment | 24 May, 2019

Australian pharmaceutical firm Phebra has continued its international business expansion with the opening of its subsidiary in Montreal, Canada. The new entity, Phebra Canada, will be ...Read more

CPhI China opens with analysis pointing to a surge in growth in 2019

Pharma |  News | 0 Comment | 24 May, 2019

New analysis released ahead of CPhI & P-MEC China (#CPhIChina and #PMECChina) – co-organized by Informa Markets, CCCMHPIE, and Shanghai Sinoexpo Informa Markets – ...Read more

Merck grants $1.99 M to ACS to improve cancer care

Pharma |  News | 0 Comment | 23 May, 2019

The Merck Foundation (the Foundation) and the American Cancer Society (ACS) announced that the Foundation awarded a $1.99 million, five-year grant to ACS to improve support and access to ca...Read more

I Holland launches online training for pharmaceutical, nutraceutical professionals

Pharma |  News | 0 Comment | 21 May, 2019

The introduction of technology enabled learning is helping companies improve the skills of their staff and is seeing huge growth in recent years. This increase is being seen through al...Read more

Takeda, Frazier Healthcare Partners to launch Phathom Pharma

Pharma |  News | 0 Comment | 21 May, 2019

Takeda Pharmaceutical and Frazier Healthcare Partners have announced a collaboration to launch Phathom Pharmaceuticals, a biopharmaceutical company focused on the development and commercial...Read more

Mabpharm announces proposed listing on the Main Board of the Hong Kong Stock Exchange

Pharma |  News | 0 Comment | 20 May, 2019

A leading biopharmaceutical company in China, Mabpharm Limited has announced that the proposed listing of its shares on the Main Board of The Stock Exchange of Hong Kong Limited.A...Read more

Daiichi Sankyo fails to hold up influenza vaccine project

Pharma |  News | 0 Comment | 20 May, 2019

Japanese pharma company Daiichi Sankyo has announced that the Company has been unable to fulfill its obligation to build a scheme to supply vaccines for 40 million people in the time allott...Read more

Lonza, Synpromics enter Biomanufacturing Partnership

Pharma |  News | 0 Comment | 17 May, 2019

Synpromics Ltd, the leader in gene control, and Lonza Pharma & Biotech announce a partnership for the commercialisation of a number of inducible promoters to improve the manuf...Read more

J & J outlines strategy to deliver Above-Market Growth

Pharma |  News | 0 Comment | 16 May, 2019

Johnson & Johnson will host a meeting with industry analysts to review the strategy of its Janssen Pharmaceutical Companies to deliver above-market, compound annual growth through 2023....Read more

Hangzhou becomes pharma hub, attracts RMB1.5 bn in bio-pharmaceutical projects

Pharma |  News | 0 Comment | 16 May, 2019

Hangzhou, capital of east China's Zhejiang Province, has seen seven bio-pharmaceutical projects implemented in the first quarter of the year, with a total investment of 1.5 b...Read more

Eisai to present data on oncology pipeline and products

Pharma |  News | 0 Comment | 16 May, 2019

Eisai Co., Ltd. announced that presentations on a series of abstracts highlighting updates regarding its in-house discovered lenvatinib mesylate (product name: Lenvima, "lenvatinib", kinase...Read more